Serious liver disease induced by infliximab

Knight DM, Trinh H, Le J et al (1993) Construction and initial characterization of a mouse–human chimeric anti-TNF antibody. Mol Immunol 30:1443–1453

Present DH, Rutgeerts P, Targan S et al (1999) Infliximab for the treatment of fistulas in patients with Crohn’s disease. N Eng J Med 340:1398–1405

Lipsky PE, van de Heijde DMFM, St Clair EW et al (2000) Infliximab and methotrexate in the treatment of rheumatoid arthritis. N Eng J Med 343:1594–1602

Saleem G, Li Shuan, MacPherson BR et al (2001) Hepatitis with interfase inflammation and IgG, IgM, and IgA anti-double-stranded DNA antibodies following infliximab therapy: comment on article by Charles et al. Arthritis Rheum 44:1966–1968

Menghini V, Arora A (2001) Infliximab-associated reversible cholestatic liver disease. Mayo Clin Proc 76:84–86

Germano V, Picchianti Diamanti A, Baccano G, Natale E, Onetti Muda A, Priori R, Valesini G (2005) Autoimmune hepatitis associated with infliximab in a patient with psoriatic arthritis. Ann Rheum Dis 64:1519–1520

Feletar M, Brockbank JE, Schentag CT, Lapp V, Gladman DD (2004) Treatment of refractory psoriatic arthritis with infliximab: a 12 month observational study of 16 patients. Ann Rheum Dis 63:156–161

Diehl AM (2000) Cytokines regulation of liver injury and repair. Immunol Rev 174:160–171

Jarret S, Cunnane G, Conaghan P et al (2003) Anti-tumor necrosis factor-α therapy-induced vasculitis: case series. J Rheumatol 30:2287–2291

Debandt M, Vittecoq O, Descamps V et al (2003) Anti-TNF-α- induced systemic lupus syndrome. Clin Rheumatol 22:56–61

Robinson WH, Genovese MC, Moreand LW (2001) Demyelinating and neurologic events reported in association with tumor necrosis factor alfa antagonism. Arthritis Rheum 44:1977–1983

Bloom BJ (2000) Development of diabetes mellitus during etanercept therapy in a child with systemic-onset juvenile rheumatoid arthritis. Arthritis Rheum 46:2606–2608

Stratigos AJ, Antoniou C, Stamathioudaki S et al (2004) Discoid lupus erythematosus-like eruption induced by infliximab. Clin Exp Dermatol 29:150–153

Foeldvari I, Krüger E, Schneider T (2003) Acute, non-obstructive, sterile cholecystitis associated with etanercept and infliximab for the treatment of juvenile polyarticular rheumatoid arthritis. Ann Rheum Dis 62:908–909

Pisetsky DS (2000) Tumor necrosis factor α blockers and the induction of anti-DNA autoantibodies. Arthritis Rheum 43:2381–2382

Diamantis I, Boumpas DT (2004) Autoimmune hepatitis: evolving concepts. Autoimmun Rev 3:207–214

Vergani D, Mieli-Vergani G (2003) Autoimmune hepatitis. Autoimmun Rev 2:241–247